Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la base de données des Annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
Obeticholic acid or its salts I MAY / 17
Obiltoxaximab I SEP / 20
Obinutuzumab I DEC / 14
Oclacitinib or its salts

including but not limited to Oclacitinib maleate

I AUG / 14
Ocrelizumab I SEP / 17
Ocriplasmin I DEC / 13
Octatropine methylbromide I DEC / 13
Octreotide I DEC / 13
Ofatumumab I DEC / 13
Ofloxacin or its salts

Including but not limited to levofloxacin.

I DEC / 13
Olanzapine or its salts I DEC / 13
Olaparib I AUG / 16
Olaratumab I MAR / 18
Oleandomycin or its salts or derivatives

For human use.

I DEC / 13
Olmesartan or its salts or derivatives

Including but not limited to olmesartan medoxmil.

I DEC / 13
Olodaterol or its salts I DEC / 13
Olopatadine or its salts I DEC / 13
Olsalazine or its salts I DEC / 13
Omalizumab I DEC / 13
Ombitasvir I MAR / 15
Omeprazole or its salts

For human use - including but not limited to omeprazole, omeprazole magnesium except when sold for the 14-day treatment for frequent heartburn at a daily dose of 20 mg, in package sizes of no more than 280 mg of omeprazole.

I SEP / 14
Omeprazole or its salts

For veterinary use - including but not limited to omeprazole, omeprazole magnesium.

I DEC / 13
Omeprazole or its salts.

when sold for the 14-day treatment for frequent heartburn at a daily dose of 20 mg, in package sizes of no more than 280 mg of omeprazole

II SEP / 14
Ondansetron or its salts I DEC / 13
Opium Poppy (Papaver somniferum), its preparations, derivatives, alkaloids and saltsN

Including: (1) Opium; (2) Codeine; (3) Morphine; (4) Thebaine; and the salts, derivatives and salts of derivatives of the substances set out in subitems (1) to (4), including: Acetorphine; Acetyldihydrocodeine; Benzylmorphine; Codoxime; Desomorphine; Diacetylmorphine (heroin); Dihydrocodeine; Dihydromorphine; Ethylmorphine; Etorphine; Hydrocodone; Hydromorphinol; Hydromorphone; Methyldesorphine; Methyldihydromorphine; Metopon; Morphine-N-oxide; Myrophine; Nalorphine; Nicocodine; Nicomorphine; Norcodeine; Normorphine; Oxycodone; Oxymorphone; Pholcodine; Thebacon; but not including: Apomorphine; Cyprenorphine and its salts; Nalmefene and its salts; Naloxone and its salts; Naltrexone and its salts; Methylnaltrexone and its salts; Naloxegol and its salts; Narcotine and its salts; Papaverine and its salts; Poppy seed
 

I JUN / 02
Orbifloxacin or its salts or derivatives I DEC / 13
Orciprenaline (Metaproterenol) or its salts I DEC / 13
Orlistat I DEC / 13
Ormetoprim or its salts I DEC / 13
Ornidazole I DEC / 13
Orphenadrine citrate III SEP / 98
Orphenadrine hydrochloride I SEP / 98
Oseltamivir or its salts I DEC / 13
Osimertinib or its salts I AUG / 16
Oxacillin, or its salts or derivatives

For veterinary use

I DEC / 13
Oxaliplatin I DEC / 13
Oxanamide I DEC / 13
Oxaprozin or its salts or derivatives I DEC / 13
Oxcarbazepine I DEC / 13
Oxethazine III SEP / 98
Oxiconazole 1% for topical use U SEP / 99
Oxolinic acid or its salts I DEC / 13
Oxprenolol or its salts I DEC / 13
Oxybuprocaine and its salts benoxinate for opthalmic or parenteral use II SEP / 98
Oxybuprocaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Oxybutynin or its salts I DEC / 13
Oxymetazoline in nasal preparations for adult use and in ophthalmic products U
Oxymetazoline and its salts in nasal preparations for pediatric use II SEP / 98
Oxyphenbutazone or its salts I DEC / 13
Oxyquinoline II SEP / 98
Oxytetracycline or its salts

For veterinary use
 

I DEC / 18
Oxytocin I DEC / 13
Ozanimod or its saltsPDL I DEC / 20
Ozenoxacin or its salts I JUN / 17

54 résultats


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act